Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

INSYS Therapeutics Inc. (INSY)

0.2911   -0.004 (-1.36%) 06-18 16:00
Open: 0.2701 Pre. Close: 0.2951
High: 0.38 Low: 0.252
Volume: 11,374,030 Market Cap: 22M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.38 - 0.382 0.382 - 0.384
Low: 0.247 - 0.248 0.248 - 0.25
Close: 0.317 - 0.32 0.32 - 0.323

Technical analysis

as of: 2019-06-18 4:34:10 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.43     One year: 2.22
Support: Support1: 0.14    Support2: 0.12
Resistance: Resistance1: 1.23    Resistance2: 1.90
Pivot: 0.65
Moving Average: MA(5): 0.34     MA(20): 0.70
MA(100): 3.68     MA(250): 5.76
MACD: MACD(12,26): -0.58     Signal(9): -0.64
Stochastic oscillator: %K(14,3): 10.18     %D(3): 11.47
RSI: RSI(14): 29.33
52-week: High: 11.65  Low: 0.14  Change(%): -96.0
Average Vol(K): 3-Month: 392229  10-Days: 1819283

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
INSY has closed above bottom band by 24.4%. Bollinger Bands are 35.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 12 Jun 2019 21:07:49 Z
Insys Therapeutics Bankruptcy: INSY Stock Soars on Latest News

Wed, 12 Jun 2019 16:13:49 Z
Zynerba Up on Second Patent for Cannabidiol Candidate in 2019

Wed, 12 Jun 2019 15:15:05 Z
Biotech Stock Roundup: Celgene Submits MS Drug to FDA, INSY & CBAY Crash

Wed, 12 Jun 2019 00:08:25 Z
Insys Down on Bankruptcy News Amid Increasing Legal Expenses

Mon, 10 Jun 2019 22:07:15 Z
Insys Therapeutics Bankruptcy: INSY Stock Plunges on the News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 74.57
Shares Float (M) 73.68
% Held by Insiders
% Held by Institutions 24.60
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.380
EPS Est. Current Year -0.330
EPS Est. Next Year -0.190
EPS Est. Next Quarter -0.120
Forward EPS -0.070
Book Value (p.s.) 3390.280
PEG Ratio -0.02
Profit Margin
Operating Margin -208.49
Return on Assets (ttm) -106.9
Return on Equity (ttm) 391.9
Qtrly Rev. Growth -68.1
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -55.24
Levered Free Cash Flow (M) -45.55

Stock Valuations

P/E -0.23
P/E Growth Ratio 0.06
P/S 27083820.00
P/CF -0.43

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2015-06-08
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.